How AAIC 2026 Alzheimer’s Data Releases Could Reframe Biogen (BIIB) Investors’ Long‑Term Thesis Simply Wall St 13:02 Mon, 06 Jul
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors. The Motley Fool 09:21 Sat, 04 Jul
Biogen (BIIB) Is Up 9.9% After US$1 Billion RayThera Deal And Salanersen Win - Has The Bull Case Changed? Simply Wall St 20:52 Sun, 28 Jun
